Acadian Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,639
| Closed | -$47K | – | 1645 |
|
|
2024
Q3 | $47K | Buy |
+3,639
| New | +$47K | ﹤0.01% | 1801 |
|
|
2020
Q4 | – | Sell |
-151,585
| Closed | -$764K | – | 2197 |
|
|
2020
Q3 | $764K | Buy |
+151,585
| New | +$764K | ﹤0.01% | 1001 |
|
|
2019
Q4 | – | Sell |
-8,372
| Closed | -$35K | – | 1877 |
|
|
2019
Q3 | $35K | Sell |
8,372
-205,579
| -96% | -$859K | ﹤0.01% | 1659 |
|
|
2019
Q2 | $620K | Sell |
213,951
-630,024
| -75% | -$1.83M | ﹤0.01% | 944 |
|
|
2019
Q1 | $1.22M | Sell |
843,975
-236,902
| -22% | -$342K | 0.01% | 823 |
|
|
2018
Q4 | $2.79M | Sell |
1,080,877
-39,338
| -4% | -$102K | 0.01% | 498 |
|
|
2018
Q3 | $4.92M | Sell |
1,120,215
-210,620
| -16% | -$924K | 0.02% | 385 |
|
|
2018
Q2 | $8.16M | Sell |
1,330,835
-317,202
| -19% | -$1.94M | 0.04% | 323 |
|
|
2018
Q1 | $12M | Sell |
1,648,037
-5,936
| -0.4% | -$43.3K | 0.05% | 279 |
|
|
2017
Q4 | $13.6M | Sell |
1,653,973
-1,300
| -0.1% | -$10.7K | 0.06% | 244 |
|
|
2017
Q3 | $17.4M | Sell |
1,655,273
-16,934
| -1% | -$178K | 0.08% | 214 |
|
|
2017
Q2 | $18.4M | Buy |
1,672,207
+147,907
| +10% | +$1.63M | 0.08% | 214 |
|
|
2017
Q1 | $14.8M | Sell |
1,524,300
-130,373
| -8% | -$1.26M | 0.07% | 235 |
|
|
2016
Q4 | $17.2M | Hold |
1,654,673
| – | – | 0.08% | 213 |
|
|
2016
Q3 | $20.5M | Buy |
1,654,673
+37,450
| +2% | +$464K | 0.1% | 182 |
|
|
2016
Q2 | $17.4M | Buy |
1,617,223
+1,141,783
| +240% | +$12.3M | 0.09% | 191 |
|
|
2016
Q1 | $5.25M | Buy |
475,440
+299,857
| +171% | +$3.31M | 0.03% | 391 |
|
|
2015
Q4 | $2.14M | Sell |
175,583
-99,644
| -36% | -$1.22M | 0.01% | 559 |
|
|
2015
Q3 | $4.49M | Buy |
+275,227
| New | +$4.49M | 0.02% | 414 |
|